[
    "{\"step_by_step_thinking\": \"Cabotegravir is a medication that belongs to a class of drugs called integrase strand transfer inhibitors (INSTIs). It is primarily used for the treatment of HIV infection in combination with other antiretroviral drugs. However, it has also been studied for its potential use as pre-exposure prophylaxis (PrEP) to prevent HIV infection in individuals who are at high risk. Several clinical trials have been conducted to evaluate the effectiveness of Cabotegravir for HIV prevention. Based on the available evidence, Cabotegravir has been shown to be effective in reducing the risk of HIV transmission when used as PrEP. Therefore, the answer to the question is A. yes.\", \"answer_choice\": \"A\"}"
]